Mozart Therapeutics is a clinical-stage biopharmaceutical company committed to developing disease-modifying therapies that restore healthy immune system function in patients with autoimmune disease.
Our first-in-class CD8 Treg modulators target a fundamental cause of immune surveillance dysregulation to restore durable immune homeostasis across autoimmune disorders.
Company Details
- Employees
- 38
- Founded
- -
- Address
- 500 Fairview Ave N.,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://Mozart-tx.com
- HQ
- Seattle, WA
Mozart Therapeutics, Inc. Questions
Mozart Therapeutics, Inc.'s website is http://Mozart-tx.com
Mozart Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/mozart-therapeutics
Mozart Therapeutics, Inc. has
38 employees.
View email and phone details for 38
employees at Mozart Therapeutics, Inc..
Mozart Therapeutics, Inc.'s industry is
Biotechnology Research
Mozart Therapeutics, Inc.'s top competitors are
Sonoma Biotherapeutics, Inc.,
Immunome, Inc.,
Immusoft,
Deka Biosciences, Inc,
Tune Therapeutics,
Outpace Bio,
Faraday Pharmaceuticals, Inc.,
Indupro,
Umoja Biopharma,
Sana Biotechnology, Inc..
Mozart Therapeutics, Inc.'s categories are Biotechnology Research
Mozart Therapeutics, Inc.'s founding year is 2020
